These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
10. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA. Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867 [TBL] [Abstract][Full Text] [Related]
11. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
12. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Lee SH; Kim SH; Park TG Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451 [TBL] [Abstract][Full Text] [Related]
13. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate. Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950 [TBL] [Abstract][Full Text] [Related]
14. Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors. Gao P; Zhang X; Wang H; Zhang Q; Li H; Li Y; Duan Y Oncotarget; 2016 Jan; 7(3):2855-66. PubMed ID: 26625203 [TBL] [Abstract][Full Text] [Related]
15. Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. Kakizawa Y; Furukawa S; Kataoka K J Control Release; 2004 Jun; 97(2):345-56. PubMed ID: 15196761 [TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126 [TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles. Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732 [TBL] [Abstract][Full Text] [Related]
18. F127/Calcium phosphate hybrid nanoparticles: a promising vector for improving siRNA delivery and gene silencing. Qin L; Sun Y; Liu P; Wang Q; Han B; Duan Y J Biomater Sci Polym Ed; 2013; 24(15):1757-66. PubMed ID: 23746331 [TBL] [Abstract][Full Text] [Related]